Ratings by Oppenheimer (Jay Olson)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Immuneering Corporation | IMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2026 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2026 | BioAge Labs Inc | BIOA | New Coverage | Outperform (N/A) |
21.35 (20.29) |
-4.96% | Details | |
| 2/6/2026 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/4/2026 | Coherus Biosciences | CHRS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2026 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2026 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/27/2026 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2026 | Coherus Biosciences | CHRS | New Coverage | Outperform (N/A) |
1.64 (1.82) |
10.98% | Details | |
| 1/20/2026 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 12/31/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2025 | Q32 Bio Inc. | QTTB | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/17/2025 | Amgen | AMGN | Upgrade | Outperform (Outperform) |
326.74 (369.53) |
13.1% | Details | |
| 12/16/2025 | Nektar Therapeutics | NKTR | Maintain | Outperform (N/A) |
|
Details | ||
| 12/15/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2025 | Dyne Therapeutics | DYN | Upgrade | Outperform (Perform) |
18.44 (14.86) |
-19.41% | Details | |
| 12/8/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/12/2025 | Dyne Therapeutics | DYN | Maintain | Perform (N/A) |
|
Details | ||
| 11/11/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2025 | Inovio Pharmaceuticals | INO | Upgrade | Outperform (Outperform) |
2.12 (1.74) |
-17.92% | Details | |
| 11/11/2025 | CRISPR Therapeutics | CRSP | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/10/2025 | Nektar Therapeutics | NKTR | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/7/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2025 | MindMed | MNMD | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/30/2025 | iBio, Inc. | IBIO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2025 | Incyte | INCY | Maintain | Perform (N/A) |
|
Details | ||
| 10/27/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/21/2025 | iBio, Inc. | IBIO | New Coverage | Outperform (N/A) |
0.85 (2.61) |
207.06% | Details | |
| 10/16/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/13/2025 | Tvardi Therapeutics Inc | TVRD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2025 | Dyne Therapeutics | DYN | Downgrade | Perform (Outperform) |
14.68 (18.44) |
25.61% | Details | |
| 10/10/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2025 | Ovid Therapeutics Inc | OVID | Upgrade | Outperform (Perform) |
1.67 (1.91) |
14.37% | Details | |
| 10/8/2025 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2025 | Incyte | INCY | Downgrade | Perform (Outperform) |
87.23 (95.94) |
9.99% | Details | |
| 10/6/2025 | Skye Bioscience | SKYE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/3/2025 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2025 | Immuneering Corporation | IMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/2/2025 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/29/2025 | Centessa Pharmaceuticals | CNTA | New Coverage | Outperform (N/A) |
16.56 (28.60) |
72.71% | Details | |
| 8/25/2025 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/18/2025 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2025 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2025 | MindMed | MNMD | New Coverage | Outperform (N/A) |
9.09 (15.02) |
65.24% | Details | |
| 8/1/2025 | atai Life Sciences N.V | ATAI | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2025 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2025 | atai Life Sciences N.V | ATAI | New Coverage | Outperform (N/A) |
3.33 (3.39) |
1.8% | Details | |
| 7/16/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/23/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2025 | Incyte | INCY | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/16/2025 | Prothena Corp | PRTA | Maintain | Perform (Perform) |
|
Details | ||
| 6/9/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2025 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2025 | Axsome Therapeutics | AXSM | New Coverage | Outperform (N/A) |
107.66 (162.33) |
50.78% | Details | |
| 6/2/2025 | MindMed | MNMD | New Coverage | Outperform (N/A) |
7.26 (9.09) |
25.21% | Details | |
| 6/2/2025 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Outperform (N/A) |
38.55 (310.71) |
705.99% | Details | |
| 6/2/2025 | MediWound Ltd | MDWD | New Coverage | Outperform (N/A) |
21.96 (17.03) |
-22.45% | Details | |
| 6/2/2025 | Dyne Therapeutics | DYN | New Coverage | Outperform (N/A) |
11.96 (14.68) |
22.74% | Details | |
| 5/27/2025 | Prothena Corp | PRTA | Downgrade | Perform (Outperform) |
6.55 (9.59) |
46.41% | Details | |
| 5/21/2025 | Tvardi Therapeutics Inc | TVRD | New Coverage | Outperform (N/A) |
27.74 (3.93) |
-85.83% | Details | |
| 5/15/2025 | Jasper Therapeutics | JSPR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2025 | Sagimet Biosciences Inc | SGMT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2025 | Skye Bioscience | SKYE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2025 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2025 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2025 | Q32 Bio Inc. | QTTB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/14/2025 | Sutro Biopharma | STRO | Downgrade | Perform (Outperform) |
1.25 (25.29) |
1923.2% | Details | |
| 3/14/2025 | Nektar Therapeutics | NKTR | Upgrade | Outperform (Perform) |
0.82 (70.70) |
8521.95% | Details | |
| 3/12/2025 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2025 | Jasper Therapeutics | JSPR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2025 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/16/2025 | Neurocrine Bio. | NBIX | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/15/2025 | Biogen | BIIB | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/13/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/8/2025 | Jasper Therapeutics | JSPR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/2/2025 | Jasper Therapeutics | JSPR | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/19/2024 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2024 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2024 | Incyte | INCY | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/11/2024 | Q32 Bio Inc. | QTTB | Maintain | Outperform (N/A) |
|
Details | ||
| 12/6/2024 | Sagimet Biosciences Inc | SGMT | New Coverage | Outperform (N/A) |
5.25 (5.41) |
3.05% | Details | |
| 12/3/2024 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/27/2024 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 11/26/2024 | Amgen | AMGN | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/20/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2024 | Incyte | INCY | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/13/2024 | Voyager Therapeutics | VYGR | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/11/2024 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2024 | CRISPR Therapeutics | CRSP | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/5/2024 | Editas Medicine | EDIT | Maintain | Perform (Perform) |
|
Details | ||
| 10/31/2024 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2024 | Terns Pharmaceuticals | TERN | New Coverage | Outperform (N/A) |
6.89 (42.82) |
521.48% | Details | |
| 10/30/2024 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2024 | Prothena Corp | PRTA | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/28/2024 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2024 | Bicycle Therapeutics | BCYC | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/23/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2024 | Incyte | INCY | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/22/2024 | Neurocrine Bio. | NBIX | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/17/2024 | Galecto | GLTO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/17/2024 | Viking Therapeutic | VKTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/16/2024 | Q32 Bio Inc. | QTTB | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/15/2024 | Revolution | RVMD | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/14/2024 | Jasper Therapeutics | JSPR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2024 | Sage Therapeutics | SAGE | Maintain | Perform (N/A) |
|
Details | ||
| 10/8/2024 | Viking Therapeutic | VKTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/7/2024 | Bicycle Therapeutics | BCYC | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/30/2024 | Jasper Therapeutics | JSPR | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/25/2024 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/23/2024 | Marinus Pharmaceuticals | MRNS | Upgrade | Outperform (Perform) |
1.60 (0.55) |
-65.63% | Details | |
| 9/17/2024 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/30/2024 | Gain Therapeutics | GANX | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/22/2024 | Skye Bioscience | SKYE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2024 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2024 | Gain Therapeutics | GANX | New Coverage | Outperform (N/A) |
0.94 (3.05) |
224.47% | Details | |
| 8/2/2024 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2024 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/15/2024 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 6/25/2024 | Jasper Therapeutics | JSPR | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2024 | Skye Bioscience | SKYE | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2024 | Galecto | GLTO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/17/2024 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2024 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 5/2/2024 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2024 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/19/2024 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/17/2024 | Sage Therapeutics | SAGE | Maintain | Perform (N/A) |
|
Details | ||
| 4/16/2024 | Cognition Therapeutics | CGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/12/2024 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/11/2024 | Q32 Bio Inc. | QTTB | New Coverage | Outperform (N/A) |
21.30 (4.70) |
-77.93% | Details | |
| 4/3/2024 | Sutro Biopharma | STRO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/28/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Perform (N/A) |
|
Details | ||
| 3/26/2024 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2024 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 3/6/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2024 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2024 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Sage Therapeutics | SAGE | Maintain | Perform (N/A) |
|
Details | ||
| 2/14/2024 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2024 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 2/8/2024 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2024 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/31/2024 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/11/2024 | Sage Therapeutics | SAGE | Maintain | Perform (N/A) |
|
Details | ||
| 12/22/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/30/2023 | BioVie Inc. | BIVI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/22/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 11/13/2023 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/25/2023 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2023 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2023 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2023 | 89bio Inc. | ETNB | Downgrade | Perform (Outperform) |
15.53 (14.84) |
-4.44% | Details | |
| 10/9/2023 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/5/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/5/2023 | Sutro Biopharma | STRO | New Coverage | Outperform (N/A) |
3.16 (1.25) |
-60.44% | Details | |
| 10/5/2023 | Immunogen Inc. | IMGN | New Coverage | Perform (N/A) |
15.16 (31.25) |
106.13% | Details | |
| 9/14/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/7/2023 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/21/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/16/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2023 | Galecto | GLTO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2023 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2023 | Marinus Pharmaceuticals | MRNS | Downgrade | Perform (Outperform) |
8.68 (1.60) |
-81.57% | Details | |
| 8/9/2023 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 8/7/2023 | Sage Therapeutics | SAGE | Maintain | Perform (N/A) |
|
Details | ||
| 8/7/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2023 | Sage Therapeutics | SAGE | Downgrade | Perform (Outperform) |
36.01 (8.68) |
-75.9% | Details | |
| 8/4/2023 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 7/28/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 7/14/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 6/20/2023 | Galecto | GLTO | New Coverage | Outperform (N/A) |
2.25 (28.91) |
1184.89% | Details | |
| 6/12/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2023 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/25/2023 | Mirati Therapeutics | MRTX | Upgrade | Outperform (Perform) |
43.84 (58.70) |
33.9% | Details | |
| 5/18/2023 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2023 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 5/8/2023 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2023 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2023 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/26/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/25/2023 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/25/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2023 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/28/2023 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/22/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/14/2023 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2023 | Voyager Therapeutics | VYGR | New Coverage | Outperform (N/A) |
8.13 (3.90) |
-52.03% | Details | |
| 3/7/2023 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/6/2023 | Nektar Therapeutics | NKTR | Maintain | Perform (N/A) |
|
Details | ||
| 3/2/2023 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 2/28/2023 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2023 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2023 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2023 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2023 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2023 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 2/14/2023 | Frequency Therapeutics | FREQ | Downgrade | Perform (Outperform) |
0.76 (0.30) |
-60.53% | Details | |
| 2/13/2023 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2023 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2023 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2023 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 12/20/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 12/20/2022 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2022 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2022 | Mirati Therapeutics | MRTX | Maintain | Perform (N/A) |
|
Details | ||
| 12/6/2022 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/30/2022 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/29/2022 | Cincor Pharma Inc | CINC | Downgrade | Perform (Outperform) |
26.53 (29.06) |
9.54% | Details | |
| 11/18/2022 | Editas Medicine | EDIT | Downgrade | Perform (Outperform) |
0.00 (2.00) |
0% | Details | |
| 11/16/2022 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2022 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2022 | Cognition Therapeutics | CGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2022 | Jasper Therapeutics | JSPR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2022 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2022 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2022 | Viking Therapeutic | VKTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/25/2022 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/21/2022 | Revolution | RVMD | New Coverage | Outperform (N/A) |
18.32 (98.40) |
437.12% | Details | |
| 10/13/2022 | Relmada Therapeutics Inc | RLMD | Downgrade | Perform (Outperform) |
31.69 (4.45) |
-85.96% | Details | |
| 9/29/2022 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/29/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 8/1/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 7/21/2022 | Cincor Pharma Inc | CINC | Maintain | Outperform (N/A) |
|
Details | ||
| 7/18/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Perform (N/A) |
|
Details | ||
| 6/30/2022 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/23/2022 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/23/2022 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 6/21/2022 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/21/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 6/1/2022 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 5/11/2022 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | (N/A) |
|
Details | ||
| 5/5/2022 | Mirati Therapeutics | MRTX | Maintain | Perform (N/A) |
|
Details | ||
| 5/4/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2022 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/27/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 4/20/2022 | Nektar Therapeutics | NKTR | Maintain | Perform (N/A) |
|
Details | ||
| 4/14/2022 | Sierra Oncology Inc | SRRA | Downgrade | Perform (Outperform) |
39.52 (54.99) |
39.14% | Details | |
| 4/8/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2022 | Ayala Pharmaceuticals | AYLA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2022 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2022 | BioVie Inc. | BIVI | New Coverage | Outperform (N/A) |
3.22 (1.36) |
-57.76% | Details | |
| 3/14/2022 | Nektar Therapeutics | NKTR | Downgrade | Perform (Outperform) |
10.63 (0.82) |
-92.29% | Details | |
| 3/14/2022 | Sierra Oncology Inc | SRRA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/9/2022 | Nektar Therapeutics | NKTR | Upgrade | Outperform (Perform) |
10.34 (70.70) |
583.75% | Details | |
| 3/3/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Perform (N/A) |
|
Details | ||
| 3/1/2022 | Mirati Therapeutics | MRTX | Maintain | Perform (N/A) |
|
Details | ||
| 3/1/2022 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2022 | Editas Medicine | EDIT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2022 | Mirati Therapeutics | MRTX | Maintain | Perform (N/A) |
|
Details | ||
| 2/17/2022 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2022 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2022 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2022 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2022 | Intellia Therapeutics | NTLA | Upgrade | Outperform (Perform) |
94.53 (13.44) |
-85.78% | Details | |
| 2/4/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2022 | Cincor Pharma Inc | CINC | New Coverage | Outperform (N/A) |
19.07 (29.06) |
52.39% | Details | |
| 1/27/2022 | Sierra Oncology Inc | SRRA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/19/2022 | Sierra Oncology Inc | SRRA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/27/2021 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 12/22/2021 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/7/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 11/23/2021 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 11/10/2021 | Frequency Therapeutics | FREQ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2021 | Nektar Therapeutics | NKTR | Maintain | Perform (N/A) |
|
Details | ||
| 11/5/2021 | Intellia Therapeutics | NTLA | Maintain | Perform (N/A) |
|
Details | ||
| 11/4/2021 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Cognition Therapeutics | CGTX | New Coverage | Outperform (N/A) |
12.10 (1.03) |
-91.49% | Details | |
| 10/27/2021 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2021 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2021 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/13/2021 | Jasper Therapeutics | JSPR | New Coverage | Outperform (N/A) |
7.81 (1.38) |
-82.33% | Details | |
| 10/8/2021 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2021 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 9/27/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/21/2021 | Mirati Therapeutics | MRTX | Maintain | Perform (N/A) |
|
Details | ||
| 9/21/2021 | Denali Therapeutics Inc. | DNLI | New Coverage | Outperform (N/A) |
52.83 (19.69) |
-62.73% | Details | |
| 9/14/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2021 | Editas Medicine | EDIT | Upgrade | Outperform (Perform) |
64.32 (2.00) |
-96.89% | Details | |
| 8/9/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2021 | Intellia Therapeutics | NTLA | Maintain | Perform (N/A) |
|
Details | ||
| 8/2/2021 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2021 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/16/2021 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 7/14/2021 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 7/13/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/28/2021 | Intellia Therapeutics | NTLA | Maintain | Perform (N/A) |
|
Details | ||
| 6/24/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/21/2021 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 6/8/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/7/2021 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/1/2021 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/1/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/18/2021 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/17/2021 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/17/2021 | Mirati Therapeutics | MRTX | Downgrade | Perform (Outperform) |
156.62 (58.70) |
-62.52% | Details | |
| 5/14/2021 | Frequency Therapeutics | FREQ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2021 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Perform (N/A) |
|
Details | ||
| 5/6/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2021 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2021 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2021 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/21/2021 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/7/2021 | TherapeuticsMD | TXMD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/5/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 4/5/2021 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2021 | Frequency Therapeutics | FREQ | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2021 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/9/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 3/2/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2021 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Perform (N/A) |
|
Details | ||
| 2/25/2021 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2021 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2021 | Frequency Therapeutics | FREQ | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2021 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 2/2/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/26/2021 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/15/2021 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 12/28/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2020 | Frequency Therapeutics | FREQ | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2020 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2020 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 12/7/2020 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 12/1/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/16/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2020 | Voyager Therapeutics | VYGR | Downgrade | Perform (Outperform) |
11.20 (8.13) |
-27.41% | Details | |
| 11/10/2020 | Sierra Oncology Inc | SRRA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Perform (N/A) |
|
Details | ||
| 11/6/2020 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2020 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2020 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2020 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Perform (N/A) |
|
Details | ||
| 10/22/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/21/2020 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/6/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/23/2020 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/21/2020 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2020 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2020 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2020 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2020 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 8/4/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2020 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/28/2020 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2020 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/21/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 7/20/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/17/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/17/2020 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/14/2020 | Frequency Therapeutics | FREQ | New Coverage | Outperform (N/A) |
22.98 (0.30) |
-98.69% | Details | |
| 7/14/2020 | Relmada Therapeutics Inc | RLMD | New Coverage | Outperform (N/A) |
42.33 (31.69) |
-25.14% | Details | |
| 7/9/2020 | Prothena Corp | PRTA | Upgrade | Outperform (Perform) |
10.70 (6.55) |
-38.79% | Details | |
| 6/30/2020 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/29/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Perform (Outperform) |
77.49 (19.00) |
-75.48% | Details | |
| 6/26/2020 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/24/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/23/2020 | CRISPR Therapeutics | CRSP | Maintain | Outperform (N/A) |
|
Details | ||
| 6/18/2020 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/12/2020 | Bicycle Therapeutics | BCYC | New Coverage | Outperform (N/A) |
17.11 (5.19) |
-69.67% | Details | |
| 6/9/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/1/2020 | Kura Oncology | KURA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/27/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Perform (N/A) |
|
Details | ||
| 5/18/2020 | Nektar Therapeutics | NKTR | Maintain | Perform (N/A) |
|
Details | ||
| 5/12/2020 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2020 | Kura Oncology | KURA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2020 | Karuna Therapeutics Inc. | KRTX | New Coverage | Outperform (N/A) |
86.65 (329.83) |
280.65% | Details | |
| 4/27/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2020 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/21/2020 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/13/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2020 | Millendo Therapeutics Inc. | MLND | Downgrade | Perform (Outperform) |
4.85 (1.06) |
-78.14% | Details | |
| 3/30/2020 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2020 | CymaBay Therapeutic | CBAY | Upgrade | Outperform (Perform) |
1.54 (32.48) |
2009.09% | Details | |
| 3/9/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2020 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2020 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 2/7/2020 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/6/2020 | Voyager Therapeutics | VYGR | New Coverage | Outperform (N/A) |
12.08 (3.90) |
-67.72% | Details | |
| 1/31/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2020 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 1/28/2020 | Sierra Oncology Inc | SRRA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2020 | Nektar Therapeutics | NKTR | Maintain | Perform (N/A) |
|
Details | ||
| 1/21/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/10/2020 | Portola Pharmaceuticals | PTLA | Downgrade | Perform (Outperform) |
24.74 (18.03) |
-27.12% | Details | |
| 1/3/2020 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 12/20/2019 | Marinus Pharmaceuticals | MRNS | New Coverage | Outperform (N/A) |
1.50 (0.55) |
-63.33% | Details | |
| 12/9/2019 | 89bio Inc. | ETNB | New Coverage | Outperform (N/A) |
27.50 (14.84) |
-46.04% | Details | |
| 12/6/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 12/6/2019 | Sierra Oncology Inc | SRRA | New Coverage | Outperform (N/A) |
0.42 (54.99) |
12992.86% | Details | |
| 12/2/2019 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2019 | CymaBay Therapeutic | CBAY | Downgrade | Perform (Outperform) |
5.55 (32.48) |
485.23% | Details | |
| 11/25/2019 | UPS | UPS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2019 | The Medicines Company | MDCO | Downgrade | Perform (Outperform) |
69.76 (84.90) |
21.7% | Details | |
| 11/19/2019 | The Medicines Company | MDCO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2019 | Nektar Therapeutics | NKTR | Maintain | Perform (N/A) |
|
Details | ||
| 11/7/2019 | Portola Pharmaceuticals | PTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | The Medicines Company | MDCO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2019 | Acadia Pharmaceuticals | ACAD | New Coverage | Perform (N/A) |
42.51 (22.16) |
-47.87% | Details | |
| 10/24/2019 | Nektar Therapeutics | NKTR | New Coverage | Outperform (N/A) |
17.20 (70.70) |
311.05% | Details | |
| 10/22/2019 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2019 | TherapeuticsMD | TXMD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/15/2019 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/14/2019 | Enanta Pharmaceuticals | ENTA | Maintain | Perform (N/A) |
|
Details | ||
| 9/5/2019 | Incyte | INCY | Upgrade | Outperform (Perform) |
80.06 (87.23) |
8.96% | Details | |
| 9/3/2019 | The Medicines Company | MDCO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/3/2019 | The Medicines Company | MDCO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/22/2019 | TherapeuticsMD | TXMD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2019 | MediWound Ltd | MDWD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2019 | Millendo Therapeutics Inc. | MLND | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/25/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 7/25/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2019 | Intec Pharma Ltd. | NTEC | Downgrade | Perform (Outperform) |
2.99 (9.63) |
222.07% | Details | |
| 7/16/2019 | Viking Therapeutic | VKTX | New Coverage | Outperform (N/A) |
8.23 (32.98) |
300.73% | Details | |
| 7/16/2019 | Millendo Therapeutics Inc. | MLND | New Coverage | Outperform (N/A) |
10.67 (4.85) |
-54.55% | Details | |
| 7/15/2019 | The Medicines Company | MDCO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/18/2019 | Mirati Therapeutics | MRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/11/2019 | TherapeuticsMD | TXMD | Maintain | Outperform (N/A) |
|
Details | ||
| 6/11/2019 | CymaBay Therapeutic | CBAY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2019 | Intec Pharma Ltd. | NTEC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2019 | Kura Oncology | KURA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2019 | TherapeuticsMD | TXMD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/26/2019 | The Medicines Company | MDCO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2019 | Acorda Therapeutics, Inc. | ACOR | Maintain | Perform (N/A) |
|
Details | ||
| 3/21/2019 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2019 | Incyte | INCY | Maintain | Perform (N/A) |
|
Details | ||
| 2/14/2019 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2019 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2019 | MediWound Ltd | MDWD | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2018 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2018 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/6/2018 | Conatus Pharmaceuticals | CNAT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2018 | Madrigal Pharmaceuticals | MDGL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2018 | Intercept Pharmaceuticals | ICPT | Upgrade | Outperform (Perform) |
100.88 (77.49) |
-23.19% | Details | |
| 11/8/2018 | Portola Pharmaceuticals | PTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2018 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/11/2018 | Sage Therapeutics | SAGE | New Coverage | Outperform (N/A) |
127.60 (8.68) |
-93.2% | Details | |
| 9/4/2018 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/27/2018 | Portola Pharmaceuticals | PTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2018 | TherapeuticsMD | TXMD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/12/0024 | SYKE Bioscience | SKYE | New Coverage | Outperform (N/A) |
54.00 (0.72) |
-98.67% | Details |
